Use of Magnesium Sulphate in the Anaesthetic Management of Pheochromocytoma in Pregnancy

1988 ◽  
Vol 8 (3) ◽  
pp. 149
Author(s):  
M. F.M. James ◽  
K. R.L. Huddle ◽  
A. D. Owen ◽  
B. W. Van der Veen
Keyword(s):  
Magnesium Sulphate ◽  
Anaesthetic Management ◽  
In Pregnancy

scholarly journals Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma in pregnancy

1988 ◽  
Vol 35 (2) ◽  
pp. 178-182 ◽  
Author(s):  
Michael F. M. James ◽  
Kenneth R. L. Huddle ◽  
Anthony D. Owen ◽  
B. W. Veen
Keyword(s):  
Magnesium Sulphate ◽  
Anaesthetic Management ◽  
In Pregnancy

Obstetric anaesthesia and analgesia

2021 ◽  
pp. 837-898
Author(s):  
James Eldridge ◽  
Nicola Cox ◽  
Alisha Allana ◽  
Heidi Lightfoot
Keyword(s):  
Pregnant Patient ◽  
Anaesthetic Management ◽  
Labour Analgesia ◽  
Failed Intubation ◽  
Obstetric Anaesthesia ◽  
Obstetric Haemorrhage ◽  
Elevated Liver Enzymes ◽  
Maternal Sepsis ◽  
Obstetric Surgery ◽  
In Pregnancy

This chapter discusses the anaesthetic management of the pregnant patient, for labour analgesia as well as surgical intervention. It begins with a description of the physiological and pharmacological changes of pregnancy. It describes methods of labour analgesia, including remifentanil, and epidural analgesia and its complications, such as post dural puncture headache (PDPH). It describes anaesthesia for Caesarean section (both regional and general); failed intubation; antacid prophylaxis; postoperative analgesia; retained placenta; in utero fetal death; hypertensive disease of pregnancy (pre-eclampsia, eclampsia and the hypertension, elevated liver enzymes and low platelets (HELLP) syndrome); massive obstetric haemorrhage; placenta praevia and morbidly adherent placenta (placenta accreta, increta and percreta); amniotic fluid embolism (AFE); maternal sepsis, and maternal resuscitation. It discusses comorbidity in pregnancy such as obesity and cardiac disease, and the patient who requires non-obstetric surgery while pregnant. It provides information on safe prescribing in pregnancy and breast-feeding.

Endocrine and autoimmune disorders

2016 ◽  
Author(s):  
Mirjana Kendrisic ◽  
Borislava Pujic
Keyword(s):  
Gestational Diabetes ◽  
Autoimmune Diseases ◽  
Pregnancy Outcome ◽  
Intensive Therapy ◽  
Anaesthetic Management ◽  
Autoimmune Disorders ◽  
Endocrine Disorders ◽  
Childbearing Age ◽  
Long Term Outcome ◽  
In Pregnancy

Advanced maternal age and increasing numbers of women of childbearing age with endocrine and autoimmune disorders have become the challenge for both anaesthetists and obstetricians. Genetic studies have provided new insight into underlying causes of endocrine disorders and prenatal prediction of inheritance. The expression of endocrine disease may influence the interpretation of diagnostic laboratory testing during pregnancy. Better understanding of the pathophysiological mechanisms enables new therapeutic approaches which can compromise pregnancy outcome. Although only a small number of drugs have been shown through clinical studies to be safe for use in pregnancy, intensive therapy for chronic disease is usually needed. Thus, anaesthetic management of women with endocrine disorders in pregnancy has become more complex. The most frequently encountered endocrine disorders during pregnancy include gestational diabetes mellitus and thyroid and adrenal disorders. Gestational diabetes has become increasingly common in pregnant women. Not only does it influence pregnancy outcome, but it also carries a risk for mother and offspring of developing type 2 diabetes later in life. Intensive glucose control may prevent maternal and fetal complications and improve long-term outcome. Pregnancy itself has been found to influence the course of autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus. However, autoimmune diseases may have adverse consequences for maternal, fetal, and neonatal health. There is a relative paucity of literature concerning anaesthetic management of autoimmune diseases. Early recognition and immediate treatment of the common complications have been the key elements to achieving the ultimate goal—good pregnancy outcome.

Anaesthetic management of Ludwig’s angina in pregnancy

2009 ◽  
Vol 18 (1) ◽  
pp. 96-97 ◽  
Author(s):  
Subramanyam Rajeev ◽  
Nidhi Bidyut Panda ◽  
Yatindra Kumar Batra
Keyword(s):  
Anaesthetic Management ◽  
Ludwig’S Angina ◽  
In Pregnancy ◽  
Ludwig's Angina

scholarly journals Eclampsia An Obstetric Disaster

2004 ◽  
Vol 43 (151) ◽  
pp. 49-55
Author(s):  
P Pradhan
Keyword(s):  
Developing Countries ◽  
Perinatal Mortality ◽  
Magnesium Sulphate ◽  
Caesarean Section Rate ◽  
Cortical Blindness ◽  
Antihypertensive Drug Therapy ◽  
Routine Practice ◽  
Electrolyte Balance ◽  
Mortality And Morbidity ◽  
In Pregnancy

Eclampsia has been graded as fatal and dreadful disease even before Christ and is the important cause ofmaternal and perinatal mortality in developed and developing countries. Severe morbidity associated witheclampsia include placental abruptio, cerebral haemorrhage, cortical blindness, renal failure, disseminatedintravascular coagulopathy, pulmonary oedema, psychosis and growth retardation and preterm or both.Present management of eclampsia aims to stop the convulsions, its recurrences, control of blood pressureand correct fluid and electrolyte balance and delivery of the baby. There have been great controversiesabout the best anticonvulsants to use. The randomised trials comparing magnesium sulphate with diazepamor phenytoin showed greater efficacy of magnesium sulphate in the control and prevention of recurrence offits. Perinatal mortality is also better with magnesium sulphate. Intramuscular injection is painful andlocal abscess formation at the site of injection is possible. Control of dose is better with intravenous routetherefore preferred. Magnesium sulphate should be continued for 24 hours after the delivery or after thelast fit. Antihypertensive drug therapy is now a routine practice in the management of pre-eclampsia andeclampsia. Methyl dopa, Lobetelol, Nefedipine are well tried in pregnancy and safe in pregnancy. However,hydralazine intravenous is good for quick and smooth control of blood pressure. Termination of pregnancyhas been an important part of the management of eclampsia. Studies have shown that maternal outcomesseems better with caesarean delivery compared to vaginal delivery. The caesarean section rate is high at26.3-80.4% in different studies. Recently maternal mortality and morbidity has been greatly improvedeven in developing countries by better control of fits by magnesium sulphate and caring them in intensivecare unit.Key Words: Eclampsia, Anticonvulsants, Antihypertensives, Delivery.

Sign in / Sign up

Export Citation Format

Share Document